HESTER BIOSCIENCES
Back to Income Statement
|
HESTER BIOSCIENCES Last 5 Year Revenue History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Net Sales | ₹311 Cr | ₹305 Cr | ₹266 Cr | ₹235 Cr | ₹214 Cr |
What is the latest Revenue of HESTER BIOSCIENCES ?
| Year | Revenue |
|---|---|
| Mar2026 | ₹311 Cr |
| Mar2025 | ₹305 Cr |
| Mar2024 | ₹266 Cr |
| Mar2023 | ₹235 Cr |
| Mar2022 | ₹214 Cr |
How is Revenue of HESTER BIOSCIENCES Trending?
| Years | Revenue | % Change | |
|---|---|---|---|
| Mar2026 | ₹311 Cr | 2.15 | |
| Mar2025 | ₹305 Cr | 14.45 | |
| Mar2024 | ₹266 Cr | 13.23 | |
| Mar2023 | ₹235 Cr | 9.65 | |
| Mar2022 | ₹214 Cr | - | |
Compare Revenue of peers of HESTER BIOSCIENCES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| HESTER BIOSCIENCES | ₹2,110.4 Cr | 1.9% | -1.9% | 18.1% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹465,471.0 Cr | -0.5% | 0.8% | 19% | Stock Analytics | |
| DIVIS LABORATORIES | ₹226,631.0 Cr | 2.2% | 23.1% | 27.4% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹185,157.0 Cr | -2.6% | -1.6% | 36% | Stock Analytics | |
| CIPLA | ₹118,108.0 Cr | 0.8% | 2.5% | -3.7% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹100,578.0 Cr | 2.6% | -2.4% | -5.6% | Stock Analytics | |
HESTER BIOSCIENCES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| HESTER BIOSCIENCES | 1.9% |
-1.9% |
18.1% |
| SENSEX | -0.4% |
0.8% |
-3% |
You may also like the below Video Courses